Search Results - "Guo, Nuojin"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Comparison of the second-line treatments for patients with small cell lung cancer sensitive to previous platinum-based chemotherapy: A systematic review and Bayesian network analysis by Shi, Hekai, Guo, Nuojin, Zhao, Zeming, Liu, Ligang, Ni, Tianyi, Zhang, Jinye, Lu, Yingjie

    Published in Frontiers in oncology (16-03-2023)
    “…It remains unclear what the best second-line treatment is for patients with small-cell lung cancer sensitive to previous platinum-based chemotherapy. We…”
    Get full text
    Journal Article
  2. 2

    Hyperuricemia Increases the Risk of Atrial Fibrillation: A Systematic Review and Meta-Analysis by Gao, Zheng, Shi, Hekai, Xu, Wei, Guan, Zhengzhao, Su, Xiuxiu, Guo, Nuojin, Ma, Huijie

    Published in International journal of endocrinology (21-08-2022)
    “…Association between hyperuricemia (HUA) and atrial fibrillation (AF) remains unclear. We reviewed clinical evidence and aimed to determine whether…”
    Get full text
    Journal Article
  3. 3

    Causal relationships of lifestyle behaviours and body fat distribution on diabetic microvascular complications: a Mendelian randomization study by Guo, Nuojin, Shi, Hekai, Zhao, Hongmei, Abuduani, Yierfan, Chen, Da, Chen, Xishuang, Wang, Hua, Li, Peicheng

    Published in Frontiers in genetics (08-07-2024)
    “…To determine the causal correlations of lifestyle behaviours and body fat distribution on diabetic microvascular complications through a Mendelian…”
    Get full text
    Journal Article
  4. 4

    Comparative Efficacy and Safety of Glucagon-like Peptide-1 Receptor Agonists in Children and Adolescents with Obesity or Overweight: A Systematic Review and Network Meta-Analysis by Liu, Ligang, Shi, Hekai, Shi, Yufei, Wang, Anlin, Guo, Nuojin, Tao, Heqing, Nahata, Milap C

    Published in Pharmaceuticals (Basel, Switzerland) (24-06-2024)
    “…Four glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have been used in children and adolescents with obesity or overweight. This network meta-analysis…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Comparison of the efficacy and safety of hypoglycemic treatments in patients with non-alcoholic fatty liver disease and type-2 diabetes: a systematic review and Bayesian network analysis by Guo, Nuojin, Shi, Hekai, Zhang, Hao, Wang, Hua

    Published in European journal of clinical pharmacology (01-11-2023)
    “…Purpose The association between non-alcoholic fatty liver disease (NAFLD) and metabolic disorders, especially type-2 diabetes (T2DM), has been proven to be…”
    Get full text
    Journal Article
  7. 7

    ASSOCIATION BETWEEN RETINAL PIGMENT EPITHELIUM TEAR AND ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY: A Systematic Review and Meta-Analysis by Shi, Hekai, Guo, Nuojin, Zhao, Zeming, Duan, Jialiang

    Published in Retina (Philadelphia, Pa.) (01-02-2024)
    “…To identify the prevalence of retinal pigment epithelium tear (RPET) after anti-vascular endothelial growth factor (VEGF) therapy and determine the efficacy of…”
    Get full text
    Journal Article
  8. 8

    Causal relationship of obesity and adiposity distribution on risk of ventral hernia by Shi, Hekai, Wu, Qian, Guo, Nuojin, Liu, Ligang, Widjaja, Jason, Yang, Jianjun, Gu, Yan

    Published in World journal of surgery (01-05-2024)
    “…Purpose Ventral hernia (VH) is a common surgical disease. Previous studies suggested that obesity is an important risk factor for VH. However, the causal…”
    Get full text
    Journal Article
  9. 9

    Global prevalence of myopic macular degeneration in general population and patients with high myopia: A systematic review and meta-analysis by Shi, Hekai, Guo, Nuojin, Zhao, Zeming, He, Xiaoyu, Li, Jiahang, Duan, Jialiang

    Published in European Journal of Ophthalmology (01-05-2024)
    “…The prevalence of myopic macular degeneration (MMD) in the general population and patients with high myopia worldwide has not been fully investigated…”
    Get full text
    Book Review Journal Article
  10. 10

    Vonoprazan‐based therapies versus PPI‐based therapies in patients with H. pylori infection: Systematic review and meta‐analyses of randomized controlled trials by Liu, Ligang, Shi, Hekai, Shi, Yufei, Wang, Anlin, Guo, Nuojin, Li, Fang, Nahata, Milap C.

    Published in Helicobacter (Cambridge, Mass.) (01-05-2024)
    “…Background This study aims to evaluate the efficacy and safety of vonoprazan‐amoxicillin (VA), vonoprazan‐amoxicillin‐clarithromycin (VAC), vonoprazan‐based…”
    Get full text
    Journal Article
  11. 11